Author

Divya Malik

Banaras Hindu UniversityORCID 0009-0000-9447-2209Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Systems Biology· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Research Focus:gene regulatory network inference· 3 Organism:human· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Research Focus:cell-cell communication· 1 Approach:machine learning (classical)· 1 Assay:metabolomics· 1

Frequent Co-Authors

Divya MishraiD· 3 shared Ekta PathakiD· 3 shared Rajeev MishraiD· 3 shared Shivangi AgrawaliD· 3 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersSystems Biology

Divya MishraORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Systems BiologyClinical & Translational OncologyPeer-reviewedOct 9, 2026

EML4-ALK Fusion Rewires Transcriptomic, miRNA, and CAF-Associated Programs in Non-Small Cell Lung Cancer

Divya Mishra, Shivangi Agrawal, Divya Malik…·Rajeev Mishra

This paper identifies transcriptomic, miRNA, and CAF-associated reprogramming in EML4-ALK fusion-positive NSCLC compared to fusion-negative tumors.

DOI 10.1007/s12094-026-04569-1

humanbulk RNA-seq

𝕏 PostBluesky

Systems BiologybioRxivPreprintFeb 13, 2026

Fusion-driven post-transcriptional network orchestrates ferroptosis resistance, dormancy, and immune remodeling in PRCC-TFE3 renal cell carcinoma

Divya Mishra, Shivangi Agrawal, Divya Malik…·Rajeev Mishra

This study identifies a fusion-driven post-transcriptional network in PRCC-TFE3 tumors that regulates ferroptosis resistance, dormancy, and immune remodeling through miRNA-mRNA interactions.

DOI 10.64898/2026.02.12.692412

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJun 5, 2025

Integrative Transcriptomic and miRNA Analysis Reveals Immune Suppression and Metabolic Reprogramming in FGFR3-TACC3 Fusion-Positive versus Fusion-Negative Bladder Cancer

Divya Mishra, Shivangi Agrawal, Divya Malik…·Rajeev Mishra

This study identifies immune suppression and metabolic reprogramming in FGFR3-TACC3 fusion-positive bladder cancer through transcriptomic and miRNA analysis, revealing fusion-specific regulatory interactions and potential therapeutic targets.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky